Pfizer
(NYSE) PFE
Pfizer Financials at a Glance
Market Cap
$153.76B
Revenue (TTM)
$62.58B
Net Income (TTM)
$7.77B
EPS (TTM)
$1.36
P/E Ratio
19.95
Dividend
$1.72
Beta (Volatility)
0.42 (Low)
Dividend
$1.72
Beta (Volatility)
0.42 (Low)
Price
$27.05
Volume
29,124,601.176
Open
$27.73
Price
$27.05
Volume
29,124,601.176
Open
$27.73
Previous Close
$27.04
Daily Range
$27.02 - $27.77
52-Week Range
$20.91 - $27.94
Dividend
$1.72
Beta (Volatility)
0.42 (Low)
Price
$27.05
Volume
29,124,601.176
Open
$27.73
Previous Close
$27.04
Daily Range
$27.02 - $27.77
52-Week Range
$20.91 - $27.94
PFE News
PFE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pfizer
Industry
Pharmaceuticals
Sector
Health CareEmployees
75,000
CEO
Albert Bourla, PhD, DVM
Website
www.pfizer.comHeadquarters
New York City, NY 10001-2192, US
PFE Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
25%
Net Income Margin
12%
Return on Equity
9%
Return on Capital
9%
Return on Assets
4%
Earnings Yield
5.01%
Dividend Yield
0.06%
Payout Ratio
1.26%
Stock Overview
Market Cap
$153.76B
Shares Outstanding
5.69B
Volume
29.12M
Short Interest
0.00%
Avg. Volume
45.30M
Financials (TTM)
Gross Profit
$44.01B
Operating Income
$15.44B
EBITDA
$15.10B
Operating Cash Flow
$11.71B
Capital Expenditure
$2.63B
Free Cash Flow
$9.08B
Cash & ST Invst.
$13.60B
Total Debt
$67.42B
Pfizer Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.56B
-1.2%
Gross Profit
$12.29B
-5.3%
Gross Margin
69.97%
N/A
Market Cap
$153.76B
N/A
Market Cap/Employee
$1.90M
N/A
Employees
81,000
N/A
Net Income
$1.65B
-508.9%
EBITDA
$756.00M
-85.3%
Quarterly Fundamentals
Net Cash
$53.82B
-24.7%
Accounts Receivable
$11.87B
-19.6%
Inventory
$10.65B
-1.8%
Long Term Debt
$63.93B
+12.7%
Short Term Debt
$3.48B
-49.8%
Return on Assets
3.73%
N/A
Return on Invested Capital
9.02%
N/A
Free Cash Flow
$4.50B
-22.4%
Operating Cash Flow
$5.35B
-20.4%